Guided Therapeutics (GTHP) Shares Outstanding (Entity) (2010 - 2026)
Guided Therapeutics (GTHP) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 1.73 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 383.57 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 576.60 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 377.40 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 451.69 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 977.43 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 97.50 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | 96.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 96.54 Mn |
| Dec 31, 2025 | 86.15 Mn |
| Sep 30, 2025 | 83.60 Mn |
| Jun 30, 2025 | 78.97 Mn |
| Mar 31, 2025 | 77.97 Mn |
| Dec 31, 2024 | 65.13 Mn |
| Sep 30, 2024 | 60.46 Mn |
| Jun 30, 2024 | 56.27 Mn |
| Mar 31, 2024 | 54,750.00 |
| Dec 31, 2023 | 54.11 Mn |
| Sep 30, 2023 | 52.04 Mn |
| Jun 30, 2023 | 51.01 Mn |
| Mar 31, 2023 | 50.81 Mn |
| Dec 31, 2022 | 32.51 Mn |
| Sep 30, 2022 | 34.83 Mn |
| Jun 30, 2022 | 27.58 Mn |
| Mar 31, 2022 | 22.32 Mn |
| Dec 31, 2021 | 13.67 Mn |
| Sep 30, 2021 | 13.42 Mn |
| Jun 30, 2021 | 13.28 Mn |